Generics
Dr Reddy's Laboratories receives US court approval to launch generic version of Indivior's Suboxone
14 February 2019 - India-based Dr Reddy's Laboratories has received approval from the United States court to introduce a generic version of Indivior's Suboxone (buprenorphine and naloxone) s...
Vitruvias Therapeutics Enters into a Semi-Solid (Topical) Licensing Agreement with Hong Kong-Based Bright Future
11 February 2019 - - Alabama, US-based finished-dose generic drug company Vitruvias Therapeutics Inc. has entered into a collaborative development agreement with Hong Kong-based pharmaceutical company...
Teva Launches Generic Version of Adcirca in the United States
7 February 2019 - - Israeli generic drug developer Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) (TASE: TEVA) has launched ALYQ, a generic version of Adcirca (tadalafil) tablets, 20 mg in the US, ...
Perrigo awarded US FDA's final approval for AB Rated generic Zovirax Cream 5%
7 February 2019 - Health and wellness company Perrigo Company plc (NYSE:PRGO)(TASE:PRGO) reported on Wednesday the receipt of the final approval from the US Food and Drug Administration (FDA) for its ...
Teva Receives Positive Committee for Medicinal Products for Human Use Opinion for Ajovy for the Prophylaxis of Migraine in Adults
1 February 2019 - - The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended granting a marketing authorisation for Ajovy (fremanezumab) 225 mg solution for ...
Mylan wins US FDA approval for Wixela Inhub for treating asthma & COPD patients
1 February 2019 - Pharmaceutical company Mylan NV (NASDAQ:MYL) reported on Thursday the receipt of the US Food and Drug Administration's (FDA) approval for Wixela Inhub (fluticasone propionate an...